Published in Cancer Res on July 01, 2003
Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev (2010) 2.44
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med (2005) 2.25
Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci U S A (2007) 1.85
MicroRNA expression after ionizing radiation in human endothelial cells. Radiat Oncol (2010) 1.38
Therapeutic targeting of the prostate cancer microenvironment. Nat Rev Urol (2010) 1.22
Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect. Tissue Eng Part A (2009) 1.05
Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model. Radiat Oncol (2009) 1.03
MiR-200c increases the radiosensitivity of non-small-cell lung cancer cell line A549 by targeting VEGF-VEGFR2 pathway. PLoS One (2013) 1.00
Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity. Exp Mol Med (2008) 1.00
The role of PDGF in radiation oncology. Radiat Oncol (2007) 0.97
Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1alpha-mediated tumor apoptotic switch. J Clin Invest (2007) 0.97
In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells. Radiat Oncol (2012) 0.96
Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2. J Immunother (2010) 0.94
Phospholipase Cγ1 connects the cell membrane pathway to the nuclear receptor pathway in insect steroid hormone signaling. J Biol Chem (2014) 0.92
Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo. BMC Cancer (2007) 0.92
Molecular ultrasound imaging of early vascular response in prostate tumors irradiated with carbon ions. Neoplasia (2009) 0.91
Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: experimental models and clinical perspectives. Cell Cycle (2009) 0.90
The addition of Sunitinib to radiation delays tumor growth in a murine model of glioblastoma. Neurol Res (2012) 0.90
HIF-1 alpha: a key survival factor for serum-deprived prostate cancer cells. Prostate (2008) 0.88
Small molecule receptor tyrosine kinase inhibitor of platelet-derived growth factor signaling (SU9518) modifies radiation response in fibroblasts and endothelial cells. BMC Cancer (2006) 0.87
Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer. Radiat Oncol (2012) 0.86
Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models. Oncol Lett (2012) 0.85
Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy. Cancer Sci (2012) 0.84
Radiation-Triggered NF-κB Activation is Responsible for the Angiogenic Signaling Pathway and Neovascularization for Breast Cancer Cell Proliferation and Growth. Breast Cancer (Auckl) (2012) 0.80
Cell survival following radiation exposure requires miR-525-3p mediated suppression of ARRB1 and TXN1. PLoS One (2013) 0.80
Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer. Nanomedicine (2015) 0.79
Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo. Strahlenther Onkol (2010) 0.79
Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors. Clin Cancer Res (2010) 0.79
Vascular endothelial growth factor-C enhances radiosensitivity of lymphatic endothelial cells. Angiogenesis (2013) 0.78
G-protein-coupled receptor controls steroid hormone signaling in cell membrane. Sci Rep (2015) 0.78
Bicalutamide inhibits androgen-mediated adhesion of prostate cancer cells exposed to ionizing radiation. Prostate (2008) 0.78
Exogenously-added copper/zinc superoxide dismutase rescues damage of endothelial cells from lethal irradiation. J Clin Biochem Nutr (2011) 0.77
Physical supports from liver cancer cells are essential for differentiation and remodeling of endothelial cells in a HepG2-HUVEC co-culture model. Sci Rep (2015) 0.76
The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response-Biological and Clinical Aspects. Cancers (Basel) (2013) 0.76
Therapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancer. Transl Lung Cancer Res (2014) 0.75
Peptide-based targeting of the platelet-derived growth factor receptor beta. Mol Imaging Biol (2013) 0.75
SU6668 modulates prostate cancer progression by downregulating MTDH/AKT signaling pathway. Int J Oncol (2017) 0.75
Updating advances on recombinant human endostatin combined with radiotherapy for non-small cell lung cancer with brain metastasis. Transl Lung Cancer Res (2012) 0.75
Honokiol as a Radiosensitizing Agent for Colorectal cancers. Curr Colorectal Cancer Rep (2013) 0.75
Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst (2002) 3.77
A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res (2003) 3.47
Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell (2013) 2.89
PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J Clin Invest (2002) 2.31
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med (2005) 2.25
Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion. Mol Cancer Ther (2003) 2.07
Endostatin's antiangiogenic signaling network. Mol Cell (2004) 1.95
Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. Cancer Res (2009) 1.90
Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci U S A (2007) 1.85
The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants. Oncogene (2004) 1.78
Pancreatic cancer microenvironment. Int J Cancer (2007) 1.73
Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy. Clin Cancer Res (2005) 1.64
Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy. Cancer Res (2005) 1.62
The STE20 kinase HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion. Mol Cell Biol (2003) 1.52
Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev (2009) 1.47
Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM). Cancer (2005) 1.46
Paradoxical dependencies of tumor dormancy and progression on basic cell kinetics. Cancer Res (2009) 1.46
A new concept for interactive radiotherapy planning with multicriteria optimization: first clinical evaluation. Radiother Oncol (2007) 1.45
Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma. Cancer Res (2011) 1.42
Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res (2008) 1.39
Influence of irradiated volume on ureteral injury after intraoperative radiation therapy: experimental study in dogs. Radiology (2003) 1.39
MicroRNA expression after ionizing radiation in human endothelial cells. Radiat Oncol (2010) 1.38
Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy. Clin Cancer Res (2008) 1.36
Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. Cancer Res (2003) 1.35
Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res (2010) 1.35
Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res (2009) 1.35
Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer (2007) 1.31
A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma. Clin Cancer Res (2008) 1.29
Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer (2005) 1.27
Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma. Blood (2007) 1.26
Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics. Cancer Res (2012) 1.25
Comparison of human B cell activation by TLR7 and TLR9 agonists. BMC Immunol (2008) 1.25
Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. J Immunol (2003) 1.25
Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers. Biomaterials (2009) 1.24
Correction of patient positioning errors based on in-line cone beam CTs: clinical implementation and first experiences. Radiat Oncol (2006) 1.21
Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis. FASEB J (2006) 1.21
LY2109761 attenuates radiation-induced pulmonary murine fibrosis via reversal of TGF-β and BMP-associated proinflammatory and proangiogenic signals. Clin Cancer Res (2012) 1.20
FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J Exp Med (2005) 1.19
Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer. Carcinogenesis (2006) 1.16
Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis. J Theor Biol (2003) 1.16
Chromosomes are predominantly located randomly with respect to each other in interphase human cells. J Cell Biol (2002) 1.15
A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation. Radiat Environ Biophys (2009) 1.14
Molecular signaling network complexity is correlated with cancer patient survivability. Proc Natl Acad Sci U S A (2012) 1.13
4D-MRI analysis of lung tumor motion in patients with hemidiaphragmatic paralysis. Radiother Oncol (2009) 1.13
A new view of radiation-induced cancer: integrating short- and long-term processes. Part I: approach. Radiat Environ Biophys (2009) 1.11
Helical tomotherapy as a new treatment technique for whole abdominal irradiation. Strahlenther Onkol (2008) 1.09
Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer (2010) 1.09
Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial. Strahlenther Onkol (2008) 1.09
TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha. Int Immunopharmacol (2007) 1.09
Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid. Mol Cancer Ther (2008) 1.09
Intraoperative electron radiotherapy for the management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys (2009) 1.08
Computed tomography monitoring of radiation-induced lung fibrosis in mice. Invest Radiol (2004) 1.08
Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study. Chemotherapy (2007) 1.07
Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition. Int J Radiat Oncol Biol Phys (2010) 1.07
Endostatin: the logic of antiangiogenic therapy. Drug Resist Updat (2005) 1.07
Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution. Int J Radiat Oncol Biol Phys (2005) 1.06
Biological effects of proton radiation: what we know and don't know. Radiat Res (2013) 1.06
Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells. Int J Radiat Oncol Biol Phys (2004) 1.05
Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761. Neoplasia (2011) 1.04
Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo. Cancer Chemother Pharmacol (2010) 1.03
Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model. Radiat Oncol (2009) 1.03
Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons. Radiat Oncol (2008) 1.03
Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base. Cancer (2009) 1.02
Long-term outcome and patterns of failure in patients with advanced head and neck cancer. Radiat Oncol (2011) 1.02
Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists. BMC Immunol (2007) 1.01
Cancer stem cells in solid tumors: is 'evading apoptosis' a hallmark of cancer? Prog Biophys Mol Biol (2011) 1.01
Non-stem cancer cell kinetics modulate solid tumor progression. Theor Biol Med Model (2011) 1.01